Low miR-150-5p and miR-320b Expression Predicts Reduced Survival of COPD Patients

Low miR-150-5p and miR-320b Expression Predicts Reduced Survival of COPD Patients

Chronic obstructive pulmonary disease (COPD) is associated with an increased risk of death, reducing life expectancy on average between 5 and 7 years. The survival time after diagnosis, however, varies considerably as a result of the heterogeneity of COPD. Therefore, markers that predict individual...

Full description

Bibliographic Details
Main Authors:	Andreas Keller, Nicole Ludwig, Tobias Fehlmann, Mustafa Kahraman, Christina Backes, Fabian Kern, Claus F. Vogelmeier, Caroline Diener, Ulrike Fischer, Frank Biertz, Christian Herr, Rudolf A. Jörres, Hans-Peter Lenhof, Robert Bals, Eckart Meese
Format:	Article
Language:	English
Published:	MDPI AG 2019-09-01
Series:	Cells
Subjects:	mirna copd cancer survival
Online Access:	https://www.mdpi.com/2073-4409/8/10/1162

Similar Items

An unbiased silencing screen in muscle cells identifies miR-320a, miR-150, miR-196b, and miR-34c as regulators of skeletal muscle mitochondrial metabolism
by: Dennis Dahlmans, et al.
Published: (2017-11-01)

Genome-wide MicroRNA Expression Profiles in COPD: Early Predictors for Cancer Development
by: Andreas Keller, et al.
Published: (2018-06-01)

The double face of miR-320: cardiomyocytes-derived miR-320 deteriorated while fibroblasts-derived miR-320 protected against heart failure induced by transverse aortic constriction
by: Xudong Zhang, et al.
Published: (2021-02-01)

MicroRNAs miR-142-5p, miR-150-5p, miR-320a-3p, and miR-4433b-5p in Serum and Tissue: Potential Biomarkers in Sporadic Breast Cancer
by: Tamyres Mingorance Carvalho, et al.
Published: (2022-06-01)

Expanding the immune-related targetome of miR-155-5p by integrating time-resolved RNA patterns into miRNA target prediction
by: Martin Hart, et al.
Published: (2025-12-01)

Association between expression level of the miR-320, miR-182, miR-223 and miR-486 and body composition among young Polish female volleyball players
by: Paulina Pruszkowska, et al.
Published: (2024-07-01)

Plasma exosomal miR-320d, miR-4479, and miR-6763-5p as diagnostic biomarkers in epithelial ovarian cancer
by: Shiwen Wang, et al.
Published: (2022-12-01)

MiR-320b and miR-320d as Biomarkers to Predict and Participate in the Formation of Platinum Resistance in Ovarian Cancer Patients
by: Yuan-Yuan Liu, et al.
Published: (2022-05-01)

Expression of miR-320 and miR-204 in myocardial infarction and correlation with prognosis and degree of heart failure
by: Yuanyuan Yang, et al.
Published: (2023-01-01)

Associations of Circulating MicroRNAs (miR-17, miR-21, and miR-150) and Chronic Kidney Disease in a Japanese Population
by: Ryosuke Fujii, et al.
Published: (2020-04-01)

Expression of miR-302a, miR-302b, miR-302c, miR-302d, miR-367, miR-371, miR-372, miR-373, miR-10b, miR-21 and miR-93 in cells of different histotypes of testicular germ cell tumors
by: M. S. Knyazeva, et al.
Published: (2022-03-01)

The potential role of miR-27a and miR-320a in metabolic syndrome in obese Egyptian females
by: Amira Mohamed Abd El-Jawad, et al.
Published: (2022-05-01)

Circulating miR-150 and miR-342 in plasma are novel potential biomarkers for acute myeloid leukemia
by: Fayyad-Kazan Hussein, et al.
Published: (2013-02-01)

Ebola virus infection, human Hsa-miR-1246, hsa-miR-320a and hsa-miR-196b-5p and predicted targets
by: Beuy Joob, et al.
Published: (2014-12-01)

Interactions of miR-323/miR-326/miR-329 and miR-130a/miR-155/miR-210 as prognostic indicators for clinical outcome of glioblastoma patients
by: Qiu Shuwei, et al.
Published: (2013-01-01)

Clinical relevance of microRNA miR-21, miR-31, miR-92a, miR-101, miR-106a and miR-145 in colorectal cancer
by: Schee Kristina, et al.
Published: (2012-11-01)

Clinical Variables Influence the Ability of miR-101, miR-150, and miR-21 to Predict Ventricular Remodeling after ST-Elevation Myocardial Infarction
by: Liana Maries, et al.
Published: (2023-10-01)

miR-34a-5p as molecular hub of pathomechanisms in Huntington’s disease
by: Martin Hart, et al.
Published: (2023-04-01)

The expression levels of circulating miR‐140‐3p, miR‐130a‐3p, and miR‐320b as diagnostic biomarkers in acute ischemic stroke
by: Hong‐Yan Ju, et al.
Published: (2023-09-01)

Serum levels of miR-29, miR-122, miR-155 and miR-192 are elevated in patients with cholangiocarcinoma.
by: Sven H Loosen, et al.
Published: (2019-01-01)

Potential relative quantities of miR-122 and miR-150 to differentiate hepatocellular carcinoma from liver cirrhosis
by: Gumilas, Nur Signa Aini, et al.
Published: (2022)

Potential relative quantities of miR-122 and miR-150 to differentiate hepatocellular carcinoma from liver cirrhosis
by: Nur Signa Aini Gumilas, et al.
Published: (2022-03-01)

Homocysteine metabolites inhibit autophagy by upregulating miR-21-5p, miR-155-5p, miR-216-5p, and miR-320c-3p in human vascular endothelial cells
by: Łukasz Witucki, et al.
Published: (2024-03-01)

Microvesicle-associated and circulating microRNAs in diabetic dyslipidemia: miR-218, miR-132, miR-143, and miR-21, miR-122, miR-155 have biomarker potential
by: Miruna Nemecz, et al.
Published: (2023-09-01)

Topographic Distribution of miRNAs (miR-30a, miR-223, miR-let-7a, miR-let-7f, miR-451, and miR-486) in the Plasma Extracellular Vesicles
by: Tatiana Petrova, et al.
Published: (2024-02-01)

Silencing miR-150 Ameliorates Experimental Autoimmune Encephalomyelitis
by: Zhaolan Hu, et al.
Published: (2018-07-01)

MiR-150 in HTLV-1 infection and T-cell transformation
by: Donna M. D’Agostino, et al.
Published: (2022-08-01)

The clinical significance of circulating miR-21, miR-142, miR-143, and miR-146a in patients with prostate cancer
by: Bolayırlı Ibrahim Murat, et al.
Published: (2022-01-01)

MicroRNAs miR-19, miR-340, miR-374 and miR-542 regulate MID1 protein expression.
by: Kristoffer Unterbruner, et al.
Published: (2018-01-01)

Dysregulation of miR-122, miR-574 and miR-375 in Egyptian patients with breast cancer.
by: Eman A Elghoroury, et al.
Published: (2024-01-01)

Expression of miR-145, miR-146, and miR-155 in an experimental model of arteriovenous fistula
by: Hugo Laparra-Escareño, et al.
Published: (2022-01-01)

Downregulation of miR-31, miR-155, and miR-564 in chronic myeloid leukemia cells.
by: Oshrat Hershkovitz Rokah, et al.
Published: (2012-01-01)

FAIM Is Regulated by MiR-206, MiR-1-3p and MiR-133b
by: Elena Coccia, et al.
Published: (2020-12-01)

Dysregulation of miR-122, miR-574 and miR-375 in Egyptian patients with breast cancer
by: Eman A. Elghoroury, et al.
Published: (2024-01-01)

Differential expression of miR-1297, miR-3191-5p, miR-4435, and miR-4465 in malignant and benign breast tumors
by: Abbas Mosapour, et al.
Published: (2020-08-01)

Circulating microRNAs, miR-939, miR-595, miR-519d and miR-494, Identify Cirrhotic Patients with HCC.
by: Francesca Fornari, et al.
Published: (2015-01-01)

miR-21, miR-93, miR-191, miR-let-7b, and miR-499 Expression Level in Plasma and Cerebrospinal Fluid in Patients with Prolonged Disorders of Consciousness
by: Tatiana A. Petrova, et al.
Published: (2022-12-01)

Circulating miR-320a-3p and miR-483-5p level associated with pharmacokinetic–pharmacodynamic profiles of rivaroxaban
by: Hanxu Zhang, et al.
Published: (2022-12-01)

Circulating miR-21-5p, miR-146a-5p, miR-320a-3p in patients with atrial fibrillation in combination with hypertension and coronary artery disease
by: S. V. Vasiliev, et al.
Published: (2022-01-01)

Serum miR-146a and miR-150 as Potential New Biomarkers for Hip Fracture-Induced Acute Lung Injury
by: Li Gan, et al.
Published: (2018-01-01)